Source link : https://newshealth.biz/health-news/novel-pde4-inhibitor-slows-ipf-progression/
(MedPage Today) — Novel oral agent nerandomilast slowed progression of idiopathic pulmonary fibrosis (IPF), even atop background antifibrotic therapy, the phase III FIBRONEER-IPF trial showed. Forced vital capacity (FVC) declined from baseline… Source link : https://www.medpagetoday.com/meetingcoverage/ats/115633 Author : Publish date : 2025-05-18 21:15:00 Copyright for syndicated content belongs to the linked Source.
The post Novel PDE4 Inhibitor Slows IPF Progression first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-18 21:15:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8